OTC · SMMNY
Healthcare · Medical - Devices
$22.39
Down-$0.15 (-0.66%)
Updated Sep 10, 2026, 12:11 PM
SID Score
6.8/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
SMMNY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning SMMNY.
SMMNY research
Company profile and research snapshot.
SIEMENS HEALTHINEERS ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 12, 2026 | DAY BY DAY | Sell | — |
| Jul 9, 2026 | EQUITA SIM | Buy | — |
| Jul 9, 2026 | BERENBERG | Hold | — |
| Jul 8, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Jul 1, 2026 | ODDO BHF | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 2, 2026
Delays occurring before patients reach stroke centers remain a major barrier to timely treatment across Southeast Asia, according to a new report, Strengthening Stroke System Readiness Across ASEAN, unveiled today by Siemens Healthineers at Hospital Management Asia (HMA) 2026 in Bangkok, Thailand.
Yahoo · Sep 1, 2026
At this year's Hospital Management Asia (HMA) healthcare conference, Siemens Healthineers is showcasing how artificial intelligence (AI), data and innovative technologies can transform care delivery by creating more connected pathways. HMA 2026 takes place in Bangkok, Thailand, from September 1-4.
Yahoo · Aug 27, 2026
BOSTON, August 27, 2026--Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, today announced several strategic leadership appointments, including the addition of multidisciplinary healthcare and technology experts as strategic advisors. The appointments bring expertise across AI, business development, technology, and public health to support the company’s continued growth and global expansion, building on strategic partnerships with Siemens Heal
SeekingAlpha · Aug 23, 2026
Even with conservative 3-5% ex-China EPS growth, Siemens Healthineers offers 15%+ annualized upside. Read why SEMHF stock is a Buy.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SMMNY.
